Trish Jefferson, M.D., M.H.S., is a third-year cardiology fellow with developing expertise in cardiac amyloidosis and heart failure. She completed her internal medicine training at Johns Hopkins University before joining UT Southwestern in July 2023. Dr. Jefferson is deeply committed to global medical education, facilitating virtual ECG bootcamps for internal medicine residents at the University of Zambia. She collaborates with the PEN-Plus writing group to document and evaluate screening and management practices for noncommunicable diseases in Zambian hospitals. Working with UTSW’s Justin Grodin, M.D., as an amyloidosis fellow sponsored by the Amyloidosis Research Consortium, she is involved in a number of research projects, including identifying subclinical transthyretin cardiac amyloidosis in asymptomatic carriers of the V122I TTR allele, assessing longitudinal biomarker responses to TTR-stabilizing therapy, and investigating sex-based differences in AL and ATTR cardiac amyloidosis. In addition, she serves as a sub-investigator on multiple studies, including the MAGNITUDE and DepleTTR-CM trials. She will begin her advanced heart failure and transplant fellowship at UT Southwestern in July 2026.